Cited by 140Diabetes Management and ResearchDiabetes Treatment and ManagementPatient Safety and Medication Errors

Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005–2011

Open access
Pathak, Ram D., Schroeder, Emily B., Seaquist, Elizabeth R., Zeng, Chan, Lafata, Jennifer Elston, Thomas, Abraham, Desai, Jay, Waitzfelder, Beth +6 more·2016·Diabetes Care

Abstract

OBJECTIVE: Appropriate glycemic control is fundamental to diabetes care, but aggressive glucose targets and intensive therapy may unintentionally increase episodes of hypoglycemia. We quantified the burden of severe hypoglycemia requiring medical intervention in a well-defined population of insured individuals with diabetes receiving care in integrated health care delivery systems across the U.S. RESEARCH DESIGN AND METHODS: This observational cohort study included 917,440 adults with diabetes receiving care during 2005 to 2011 at participating SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) network sites. Severe hypoglycemia rates were based on any occurrence of hypoglycemia-related ICD-9 codes from emergency department or inpatient medical encounters and reported overall and by age, sex, comorbidity status, antecedent A1C level, and medication use. RESULTS: Annual rates of severe hypoglycemia ranged from 1.4 to 1.6 events per 100 person-years. Rates of severe hypoglycemia were higher among those with older age, chronic kidney disease, congestive heart failure, cardiovascular disease, depression, and higher A1C levels, and in users of insulin, insulin secretagogues, or β-blockers (P < 0.001 for all). Changes in severe hypoglycemia occurrence over time were not clinically significant in the cohort as a whole but were observed in subgroups of individuals with chronic kidney disease, congestive heart failure, and cardiovascular disease. CONCLUSIONS: Risk of severe hypoglycemia in clinical settings is considerably higher in identifiable patient subgroups than in randomized controlled trials. Strategies that reduce the risk of hypoglycemia in high-risk patients are needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc15-0858

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In T2D, advanced CKD is a risk factor for hypoglycemia.

    “In T2D, advanced CKD is a risk factor for hypoglycemia (29,79) and, when possible, drugs that control glycemia without increasing risk of hypoglycemia are preferred.”

    From Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) (2022) · cites this paper as [79]

    The Results report substantially higher rates of severe hypoglycemia in patients with CKD than in those without it. However, the paper does not isolate advanced CKD, and its Study Population section says the cohort could not be separated by diabetes type, although approximately 95% were estimated to have T2D. The finding supports an association, not a demonstrated causal risk factor; page numbers are unavailable in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 50 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [32]Centers for Disease Control and Prevention National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA, U.S. Department of Health and Human Services, 2014 [Google Scholar]

Cited by

Sorted by citations

Authors
Pathak, R. D., Schroeder, E. B., Seaquist, E. R., Zeng, C., Lafata, J. E., Thomas, A., Desai, J., Waitzfelder, B., Nichols, G. A., Lawrence, J. M., Karter, A. J., Steiner, J. F., Segal, J., & O’Connor, P. J.
Affiliations
  • Marshfield Clinic (US)
  • Kaiser Permanente (US)
  • University of Minnesota (US)
  • Henry Ford Health (US)
  • HealthPartners (US)
  • Kaiser Permanente Northern California (US)
  • Johns Hopkins University (US)
Corresponding author
Pathak, Ram D.
Venue
Diabetes Care
Published
2015-12-17
Volume
39
Issue
3
Pages
363-370
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2239573607
Cited by
140
References
50
Citations by year
2026: 6 · 2025: 8 · 2024: 4 · 2023: 9 · 2022: 12 · 2021: 17 · 2020: 20 · 2019: 19 · 2018: 16 · 2017: 18 · 2016: 11
FWCI
13.04
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Agency for Healthcare Research and Quality (R01HS019859)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Health Professions › Emergency Medical Services › Patient Safety and Medication Errors
Keywords
severe hypoglycemia, diabetes mellitus, hypoglycemia incidence, risk factors, chronic kidney disease, congestive heart failure, cardiovascular disease, depression, glycemic control, insulin, insulin secretagogues, beta-blockers, HbA1c, integrated health system
MeSH terms
Adult, Aged, Blood Glucose, Diabetes Mellitus, Female, Humans, Hypoglycemia, Male, Middle Aged, United States, Cohort Studies, Comorbidity, Delivery of Health Care, Integrated, Disease Management, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review